AI lung cancer screening

Find who to screen.
Know which lung nodules matter.

Find patients who qualify for lung screening, even when pack-year history is missing from the chart. Then give your radiologists a cancer risk score for every lung nodule, inside the viewer they already use.

For FQHCs For Hospitals
LungAI is an investigational medical device and has not been cleared by FDA. Oatmeal Health is preparing a 510(k) premarket notification for submission to FDA. LungAI is not commercially available in the United States. Clinical performance data reflect retrospective studies on held-out datasets; results may differ in prospective use.
124,990
Americans die from lung cancer every year.

About as many as breast, prostate, and colorectal cancers combined. Most are found too late because the system never looked.

~70%

Diagnosed after the cancer has spread. Once it reaches distant organs, five-year survival is about 10%

70 to 90%

Survival rate when caught early at Stage I or II

14M+

Americans qualify for yearly lung cancer screening

<6%

Screened in underserved FQHC communities, where the gap is widest

Sources: ACS Cancer Facts 2024, USPSTF 2021, NLST, NCI SEER

Trusted Partners
Cedars-Sinai Camarena Health Fox Chase Cancer Center Stanford Health Care Mount Sinai Health System Jefferson Health Mass General Brigham
How It Works

One platform. Three partners.
Every patient found.

Lung cancer screening fails because the system is fragmented. FQHCs have the patients. Hospitals have the scanners. Payers have the incentive. We connect all three.

Doctor consulting with patient at community health center
Community Health Centers
Find the patients no one else finds
FQHCs serve 34M+ lives, many with the highest smoking prevalence and lowest screening rates. LungIQ scans EHR data to identify eligible patients, even when smoking history was never entered into structured fields.
  • LungIQ 0.96 AUROC patient identification
  • 9x faster than manual chart review
  • Eligible patients referred to partner imaging centers
  • Finds smoking history buried in free text notes
Find hidden patients
Radiologist reviewing CT lung scan
Hospitals & Imaging Centers
Screen more patients. Read with confidence.
Hospitals receive a steady referral pipeline from FQHC partners. LungAI is designed to add an AI second opinion inside the radiologist's existing viewer. No new workstation. No new login.
  • LungIQ Identify eligible patients in your own system too
  • LungAI Cancer risk score, 0 to 10, per nodule
  • Score appears in the viewer radiologists already use
  • Fewer missed cancers. Fewer unnecessary biopsies.
Review the evidence
LungAI is investigational and not FDA cleared. Performance from a retrospective study on held-out NLST data. Results may differ in clinical use.
Healthcare data analytics dashboard
Health Plans
Turn screening spend into measurable savings
Lung cancer screening is already a covered benefit. Payers are paying for it. The question is what they are getting from it. Finding cancer at an earlier stage means less intensive treatment.
  • No new coverage policy or billing model required
  • Focused on finding cancer at earlier stages
  • HEDIS lung screening measure expected (NCQA)
  • Outcomes model built with your actuaries
Partner with us
Jonathan Govette, CEO and Co-Founder of Oatmeal Health
Our Story
A mission born from personal loss
After losing more than ten family members to cancer, Jonathan Govette founded Oatmeal Health to make sure fewer families have to endure the same. We built the platform we wish had existed.
Read our story →
“
We can defuse the cancer time bomb, but only if we find people earlier.
Jonathan Govette CEO and Co-Founder

Ready to close the lung cancer screening gap?

Whether you are an FQHC, health system, or health plan, we have a program built for you.

Get started